Compare Altria Group Inc (MO) vs Zimmer Biomet Holdings Inc (ZBH) Price & Performance

Altria Group IncTrade

Zimmer Biomet Holdings IncTrade

Price performance (Past 24H)

Key statistics

Altria Group Inc vs Zimmer Biomet Holdings Inc — how do they compare? Altria Group Inc trades at $65.15 (market cap $114.13B), while Zimmer Biomet Holdings Inc trades at $97 (market cap $18.65B). The key difference: Altria Group Inc is far larger — about 6.1× Zimmer Biomet Holdings Inc's market cap, and Altria Group Inc pays the higher dividend (6.2%). Which is the better fit depends on your goals.

	MO	ZBH
Market Cap	$114.13B	$18.65B
Sector	Consumer Staples	Health
52-Week High	$74.92	$107.71
52-Week Low	$54.72	$79.58
Enterprise Value	$136.34B	$25.72B
Dividend Yield	6.2%	0.98%

View details →View details →

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Altria Group Inc

No Aura AI signal available yet.

Zimmer Biomet Holdings Inc

Zimmer Biomet (ZBH) trades at $96.55, down 0.66% on the day, with a bullish technical signal from moving averages and a consensus analyst price target of $103.56. The company reported strong Q2 2026 earnings, beating estimates with EPS of $2.07, and raised its full-year outlook. Revenue growth remains steady, supported by hips, specialty businesses, and technology, though net income margin has moderated from 2023 peaks. Recent corporate news includes a dividend declaration and expansion of its technology center in India.

The outlook for ZBH is positive, driven by consistent earnings beats and strategic growth initiatives, but investors face risks from margin pressure and increasing debt levels. The stock offers potential upside to the consensus target, supported by institutional accumulation, though competitive and macroeconomic headwinds in the medtech sector warrant caution.

Aura AI is an analytical signal, not financial advice — do your own research.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

Invesco's PEY ETF outperforms with a dividend-growth filter, offering higher returns and reliable income.24/7 Wall Street · 16 hours agoBullish Altria offers 6.3% yield with 60 years of dividend growth, trading at a low valuation amid regulatory risks.Seeking Alpha · 4 days agoBullish Altria shares drop after Q2 results miss estimates; investigation into possible misleading earnings outlook underwayPRNewsWire · 4 days agoBearish View details →

ZBH

View details →

About Altria Group Inc

Altria comprises Philip Morris USA, U.S. Smokeless Tobacco, John Middleton, Helix Innovations, and Philip Morris Capital, although the company plans to wind down Philip Morris Capital by the end of 2022. It holds a 10% interest in the world's largest brewer, Anheuser-Busch InBev. Through its tobacco subsidiaries, Altria holds the leading position in cigarettes and smokeless tobacco in the United States and the number-two spot in machine-made cigars. The company's Marlboro brand is the leading cigarette brand in the U.S. with a 43% share in 2020. Altria holds strategic investments in JUUL Labs (35% economic interest) and Cronos (42%).

About Zimmer Biomet Holdings Inc

Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants, as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly 70% of total revenue is derived from sales of large joints, another quarter comes from extremities, trauma, and related surgical products.